Total Payments
$718.09
2022 Payments
$13.23
Companies
8
Transactions
14
Medicare Patients
9,592
Medicare Billing
$3.1M
Payment Breakdown by Category
Food & Beverage$703.09 (97.9%)
Education$15.00 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $703.09 | 13 | 97.9% |
| Education | $15.00 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $243.53 | 3 | $0 (2021) |
| AbbVie Inc. | $194.17 | 4 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $107.14 | 1 | $0 (2019) |
| Allergan Inc. | $97.33 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $30.42 | 2 | $0 (2020) |
| Genentech USA, Inc. | $17.27 | 1 | $0 (2019) |
| Sandoz Inc. | $15.00 | 1 | $0 (2017) |
| Paratek Pharmaceuticals, Inc. | $13.23 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.23 | 1 | Paratek Pharmaceuticals, Inc. ($13.23) |
| 2021 | $101.73 | 1 | GENZYME CORPORATION ($101.73) |
| 2020 | $116.93 | 6 | AbbVie Inc. ($69.17) |
| 2019 | $346.20 | 4 | GENZYME CORPORATION ($124.46) |
| 2017 | $140.00 | 2 | AbbVie, Inc. ($125.00) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/14/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: ANTIBIOTIC | ||||||
| 07/28/2021 | GENZYME CORPORATION | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $101.73 | General |
| Category: Oncology | ||||||
| 10/15/2020 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2020 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2020 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Immunology | ||||||
| 06/24/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Immunology | ||||||
| 06/10/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Immunology | ||||||
| 11/22/2019 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: BioOncology | ||||||
| 11/13/2019 | GENZYME CORPORATION | LIBTAYO (Drug) | Food and Beverage | In-kind items and services | $124.46 | General |
| Category: ONCOLOGY | ||||||
| 03/04/2019 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $107.14 | General |
| Category: ONCOLOGY | ||||||
| 03/02/2019 | Allergan Inc. | BOTOX COSMETIC | Food and Beverage | In-kind items and services | $97.33 | General |
| 07/13/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 03/03/2017 | Sandoz Inc. | KERYDIN (Drug) | Education | In-kind items and services | $15.00 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,856 | 3,528 | $2.5M | $924,611 |
| 2022 | 30 | 2,643 | 3,305 | $2.4M | $860,427 |
| 2021 | 32 | 2,566 | 3,182 | $2.0M | $805,843 |
| 2020 | 23 | 1,527 | 1,826 | $1.5M | $477,794 |
Total Patients
9,592
Total Services
11,841
Medicare Billing
$3.1M
Procedure Codes
114
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 709 | 886 | $1.1M | $420,316 | 37.8% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 321 | 460 | $351,023 | $152,487 | 43.4% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 92 | 102 | $120,333 | $49,570 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 445 | 691 | $114,656 | $47,127 | 41.1% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 232 | 245 | $214,386 | $46,740 | 21.8% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 37 | 38 | $64,771 | $26,800 | 41.4% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 43 | 43 | $60,986 | $25,887 | 42.4% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2023 | 31 | 31 | $43,466 | $18,605 | 42.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 316 | 379 | $39,388 | $15,978 | 40.6% |
| 14301 | Repair of wound by transferring skin, 30.1-60.0 sq cm | Office | 2023 | 13 | 14 | $27,983 | $11,976 | 42.8% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 15 | 15 | $27,593 | $11,825 | 42.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 62 | 64 | $36,135 | $11,715 | 32.4% |
| 14061 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 14 | 14 | $25,636 | $10,915 | 42.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 112 | 112 | $23,058 | $9,377 | 40.7% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 48 | 48 | $37,938 | $8,406 | 22.2% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 38 | 38 | $34,956 | $8,004 | 22.9% |
| 15240 | Full thickness skin graft to forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 20.0 sq cm or less | Office | 2023 | 12 | 12 | $20,598 | $7,817 | 37.9% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 22 | 24 | $17,578 | $7,624 | 43.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 49 | $11,497 | $4,484 | 39.0% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 27 | 28 | $16,125 | $4,125 | 25.6% |
| 13151 | Complicated repair of wound of eyelids, nose, ears, or lip, 1.1-2.5 cm | Office | 2023 | 24 | 24 | $18,875 | $4,097 | 21.7% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 29 | 29 | $15,012 | $3,480 | 23.2% |
| 12053 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | Office | 2023 | 22 | 23 | $15,545 | $3,382 | 21.8% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 26 | 26 | $15,169 | $3,314 | 21.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $8,243 | $3,230 | 39.2% |
About Dr. Stephen Vance, M.D
Dr. Stephen Vance, M.D is a MOHS-Micrographic Surgery healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1821403247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Vance, M.D has received a total of $718.09 in payments from pharmaceutical and medical device companies, with $13.23 received in 2022. These payments were reported across 14 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($703.09).
As a Medicare-enrolled provider, Vance has provided services to 9,592 Medicare beneficiaries, totaling 11,841 services with total Medicare billing of $3.1M. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Pinehurst, NC
- Active Since 06/24/2014
- Last Updated 05/09/2019
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1821403247
Products in Payments
- LIBTAYO (Biological) $208.87
- Humira (Biological) $125.00
- LIBTAYO (Drug) $124.46
- SKYRIZI (Biological) $69.17
- TREMFYA (Drug) $30.42
- DUPIXENT (Biological) $17.34
- Erivedge (Biological) $17.27
- KERYDIN (Drug) $15.00
- NUZYRA (Drug) $13.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.